2024

Permanent URI for this communityhdl:123456789/284

Browse

Browsing 2024 by Subject "exports"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    High-Tech Industry in the EU: Policy, Economy, Statistics
    (Національна академія статистики, обліку та аудиту, 2024) Salikhova O. B.
    The analysis of the legal framework supporting the European Union’s decisions on the EU industrial sector, particularly high-tech manufacturing, shows that the European Commission maintains a long-standing commitment to prioritizing technological development in industries. To enhance their potential and competitive advantages, mechanisms of industrial, scientific-technological, and innovation policy are primarily employed. At the same time, research results show the growing trade deficit EU high-tech trade. The aim of the article is to deepen understanding on the policy and economic dimensions of high-tech activity, as well as to statistical estimates of production and international trade flows of high-tech goods in EU between 2008 and 2023. The economic-statistical analysis revealed that, since the early 2000s, the EU has gradually increased its trade deficit in high-tech goods with China. In 2009, the negative balance was €43.1 billion, rising to €73.1 billion by 2019; in 2022, the trade deficit with China reached a historic high of €129.6 billion; by the end of 2023, it was €105.5 billion. Countries such as Thailand, South Korea, Malaysia, Taiwan, and Vietnam have significantly increased their exports of high-tech goods to the EU since 2019, contributing to a growing negative balance. Before the pandemic in 2019, imports from Asian countries of high-tech goods in the groups of Electronics & Telecommunications and Computers and office machines grew at the highest rates. In the category of Electronics & Telecommunications, imports from China increased from €63,013.9 million to €89,228.1 million from 2019 to 2023; imports from Taiwan – from €3,644.7 million to €16,489.4 million; and imports from Vietnam – from €110.2 million to €14,053.8 million. In the category of Computers and office machines, imports from China increased from €40,177.4 million to €42,752.0 million; imports from Taiwan – from €802.6 million to €9,917.6 million; and imports from Vietnam – from €21.1 million to €2,787.2 million. This led to a significant trade deficit for the EU in high-tech goods from these countries. The work substantiates that the EU leadership has adopted new political documents, which prioritize reducing strategic external dependency on imports and implementing measures to enhance their effectiveness. It should serve as benchmarks for developing policies for the growth of high-tech industries in Ukraine amid wartime conditions and post-war economic recovery.
  • No Thumbnail Available
    Item
    International Trade of Pharmaceutical Products and Issues of National Security
    (Національна академія статистики, обліку та аудиту, 2024) Salikhova O . B .
    With the COVID-19 pandemic, the world entered a reality that can be called “medicines power” . The closure of factories in China due to strict quarantine, the ban on exporting certain goods from India in early 2020, the unavailability of air transportation, and blocked sea routes caused disruptions in supply and blocked value-added chains . It became evident: there is a threat of depend on the import of active pharmaceutical ingredients and medicaments, medicinal, and pharmaceutical products, production of which is concentrated in Asia . It is clear that countries with scientific, technological, innovational and production capabilities to ensure the needs of healthcare sector (including pharmaceutical goods), are less vulnerable and dependent on imported supplies (mostly from unfriendly nations) . On the contrary, countries lacking adequate resources face national security threats . These threats are especially exacerbated during epidemics, crises, environmental disasters, and military conflicts . The aim of this article is to analyze of EU policy and the key trends in the export of pharmaceutical industry products from the EU, especially after the large-scale russian military invasion of Ukraine in February 2022 (and the European Council’s strong condemnation of russia’s aggressive war against Ukraine, and the imposition of a series of sanctions); in particular the identification of the volume of exports to russia and Ukraine; the development of recommendations for Ukraine regarding the development of the pharmaceutical industry and reducing external dependence on supplies and threats to national security . The analysis showed that in 2023, russia ranked 6th among the largest EU partners for the import of medicinal products, medical and pharmaceutical goods . The EU exported medicaments, medicinal, and pharmaceutical products to russia worth €8 .8 billion (medicaments, medicinal, and pharmaceutical products became the leaders in exports from the EU to russia in 2022–2023) . Ukraine paid $1 .96 billion for the import of this goods; in 2023, the expenses increased to $2 .21 billion (close to the amount paid in 2019, which was $2 .24 billion), despite a significant decrease in Ukraine’s population due to migration, casualties, and the temporary occupation of Ukrainian territories . Since the responsibility of governments lies in efforts to care for the nation’s health, ensure the efficiency of the economic system and social stability, the article justifies the need to initiate negotiations with European partners regarding the construction of pharmaceutical enterprises (relocating from Asia), specifically for the production of pharmaceutical and biological ingredients, as well as finished medicines, within Ukraine . Such measures are a rational and politically justified decision . This will help reduce the EU and Ukraine’s external strategic dependence on supplies (including from unfriendly countries) and ensure the regulation and management of the industry’s development in national interests . In case of threats, this will allow measures to influence the structure and volume of production, which, as the 2020 lockdown showed, turned out to be impossible with the placement of production capacities in countries where the free flow of goods becomes difficult in crisis situations .